vs
ASP Isotopes Inc.（ASPI）与Biofrontera Inc.（BFRI）财务数据对比。点击上方公司名可切换其他公司
Biofrontera Inc.的季度营收约是ASP Isotopes Inc.的1.0倍（$17.1M vs $16.7M），ASP Isotopes Inc.同比增速更快（1295.7% vs 36.2%），Biofrontera Inc.自由现金流更多（$-2.4M vs $-47.4M）
ASP Isotopes Inc.是一家特种材料企业，专注于高纯度定制同位素的研发与生产，产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域，客户覆盖北美、欧洲及亚太地区。
Biofrontera Inc.是一家专注于皮肤病治疗领域的特种生物制药企业，主要研发和商业化处方类皮肤科药物，核心产品线针对光化性角化病等常见皮肤病症，主要市场覆盖美国及欧盟地区，服务皮肤科医护人员与患者。
ASPI vs BFRI — 直观对比
营收规模更大
BFRI
是对方的1.0倍
$16.7M
营收增速更快
ASPI
高出1259.5%
36.2%
自由现金流更多
BFRI
多$45.1M
$-47.4M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.7M | $17.1M |
| 净利润 | — | $5.6M |
| 毛利率 | 12.5% | — |
| 营业利润率 | — | 26.6% |
| 净利率 | — | 33.0% |
| 营收同比 | 1295.7% | 36.2% |
| 净利润同比 | -586.8% | 504.0% |
| 每股收益（稀释后） | — | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASPIBFRI
| Q4 25 | $16.7M | $17.1M | ||
| Q3 25 | $4.9M | $7.0M | ||
| Q2 25 | — | $9.0M | ||
| Q1 25 | — | $8.6M | ||
| Q4 24 | — | $12.6M | ||
| Q3 24 | — | $9.0M | ||
| Q2 24 | — | $7.8M | ||
| Q1 24 | — | $7.9M |
净利润ASPIBFRI
| Q4 25 | — | $5.6M | ||
| Q3 25 | $-12.9M | $-6.6M | ||
| Q2 25 | — | $-5.3M | ||
| Q1 25 | — | $-4.2M | ||
| Q4 24 | — | $-1.4M | ||
| Q3 24 | — | $-5.7M | ||
| Q2 24 | — | $-257.0K | ||
| Q1 24 | — | $-10.4M |
毛利率ASPIBFRI
| Q4 25 | 12.5% | — | ||
| Q3 25 | 8.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ASPIBFRI
| Q4 25 | — | 26.6% | ||
| Q3 25 | -306.1% | -89.8% | ||
| Q2 25 | — | -56.2% | ||
| Q1 25 | — | -52.9% | ||
| Q4 24 | — | -13.6% | ||
| Q3 24 | — | -55.0% | ||
| Q2 24 | — | -64.7% | ||
| Q1 24 | — | -69.1% |
净利率ASPIBFRI
| Q4 25 | — | 33.0% | ||
| Q3 25 | -263.7% | -95.1% | ||
| Q2 25 | — | -59.0% | ||
| Q1 25 | — | -48.9% | ||
| Q4 24 | — | -11.1% | ||
| Q3 24 | — | -62.9% | ||
| Q2 24 | — | -3.3% | ||
| Q1 24 | — | -131.9% |
每股收益（稀释后）ASPIBFRI
| Q4 25 | — | $0.62 | ||
| Q3 25 | $-0.15 | $-0.62 | ||
| Q2 25 | — | $-0.57 | ||
| Q1 25 | — | $-0.47 | ||
| Q4 24 | — | $0.69 | ||
| Q3 24 | — | $-0.98 | ||
| Q2 24 | — | $-0.05 | ||
| Q1 24 | — | $-2.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $333.3M | $6.4M |
| 总债务越低越好 | $14.4M | — |
| 股东权益账面价值 | $204.2M | $10.5M |
| 总资产 | $498.0M | $28.6M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资ASPIBFRI
| Q4 25 | $333.3M | $6.4M | ||
| Q3 25 | $113.9M | $3.4M | ||
| Q2 25 | — | $7.2M | ||
| Q1 25 | — | $1.8M | ||
| Q4 24 | — | $5.9M | ||
| Q3 24 | — | $2.9M | ||
| Q2 24 | — | $4.4M | ||
| Q1 24 | — | $3.8M |
总债务ASPIBFRI
| Q4 25 | $14.4M | — | ||
| Q3 25 | $13.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ASPIBFRI
| Q4 25 | $204.2M | $10.5M | ||
| Q3 25 | $74.1M | $-2.6M | ||
| Q2 25 | — | $-4.7M | ||
| Q1 25 | — | $500.0K | ||
| Q4 24 | — | $4.4M | ||
| Q3 24 | — | $5.5M | ||
| Q2 24 | — | $10.9M | ||
| Q1 24 | — | $-5.4M |
总资产ASPIBFRI
| Q4 25 | $498.0M | $28.6M | ||
| Q3 25 | $225.9M | $15.4M | ||
| Q2 25 | — | $20.1M | ||
| Q1 25 | — | $16.6M | ||
| Q4 24 | — | $22.1M | ||
| Q3 24 | — | $18.5M | ||
| Q2 24 | — | $21.6M | ||
| Q1 24 | — | $24.6M |
负债/权益比ASPIBFRI
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.8M | $-2.4M |
| 自由现金流经营现金流 - 资本支出 | $-47.4M | $-2.4M |
| 自由现金流率自由现金流/营收 | -284.7% | -13.9% |
| 资本支出强度资本支出/营收 | 57.9% | 0.0% |
| 现金转化率经营现金流/净利润 | — | -0.42× |
| 过去12个月自由现金流最近4个季度 | — | $-13.4M |
8季度趋势，按日历期对齐
经营现金流ASPIBFRI
| Q4 25 | $-37.8M | $-2.4M | ||
| Q3 25 | $-8.9M | $-3.8M | ||
| Q2 25 | — | $-3.0M | ||
| Q1 25 | — | $-4.1M | ||
| Q4 24 | — | $-1.0M | ||
| Q3 24 | — | $-1.2M | ||
| Q2 24 | — | $-4.7M | ||
| Q1 24 | — | $-3.3M |
自由现金流ASPIBFRI
| Q4 25 | $-47.4M | $-2.4M | ||
| Q3 25 | $-12.0M | $-3.8M | ||
| Q2 25 | — | $-3.0M | ||
| Q1 25 | — | $-4.1M | ||
| Q4 24 | — | $-1.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-4.8M | ||
| Q1 24 | — | $-3.4M |
自由现金流率ASPIBFRI
| Q4 25 | -284.7% | -13.9% | ||
| Q3 25 | -245.5% | -54.7% | ||
| Q2 25 | — | -33.7% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -8.1% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -60.8% | ||
| Q1 24 | — | -42.7% |
资本支出强度ASPIBFRI
| Q4 25 | 57.9% | 0.0% | ||
| Q3 25 | 64.4% | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | — | 0.7% |
现金转化率ASPIBFRI
| Q4 25 | — | -0.42× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
